Cangrelor is an intravenous platelet inhibitor used during coronary interventions to prevent blood clots. It acts by inhibiting the P2Y12 receptor on platelets. It is grouped under the following drug class(es): Antithrombotic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Kengreal and cangrelorum. Its PubChem CID is 9854012.
Cangrelor
| CAS No | 163706-06-7 |
|---|---|
| Molecular Formula | C17H25Cl2F3N5O12P3S2 |
| Molecular Weight | 776.4 g/mol |
| Synonyms | [dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cangrelor is an intravenous platelet inhibitor used during coronary interventions to prevent blood clots. It acts by inhibiting the P2Y12 receptor on platelets.
The listed CAS number is 163706-06-7.
The listed molecular formula is C17H25Cl2F3N5O12P3S2.
The listed molecular weight is 776.4 g/mol.
[dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid.
The source lists Kengreal and cangrelorum.